England’s NICE Backs Epidyolex For Seizures, Sativex For MS Spasticity
But New Guidance Rejects Cannabis-Based Drugs For Chronic Pain
Health technology assessment body NICE has given the thumbs-up to Epidyolex and Sativex, which become the first plant-derived medicinal cannabis products to secure routine NHS funding. It has also issued positive guidance on other products including nabilone, but turned down the use of cannabis-based drugs in chronic pain.
